ImmunityBio, Inc. logo

ImmunityBio, Inc. (IBRX)

Market Closed
3 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
7. 1800
-0.05
-0.69%
$
7.57B Market Cap
- P/E Ratio
- Div Yield
8,867,523 Volume
-0.93 Eps
$ 7.23
Previous Close
Add Transaction
Day Range
7.025 7.3
Year Range
1.95 12.43
Want to track IBRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

ImmunityBio, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
MM
Michael McCracken MFG Wealth Management Inc.
175,350 $1.34M $1.26M -$85,922.01 -6.39%
SK
Samira Kadam Synergy Investment Management LLC
134 $1,028 $962.12 -$65.88 -6.41%
EG
Ethan Gilbert Rialto Wealth Management LLC
50 $102.08 $359 $256.92 251.68%
CMP
Craig M. Pesce Marshall & Sterling Wealth Advisors Inc.
50 $128 $359 $231 180.47%
GFM
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
22,120 $71,951.85 $158,821.6 $86,869.75 120.73%
JCB
John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH
21,904 $168,004 $157,270.72 -$10,733.28 -6.39%
DRH
David R. Hess Wealth Management Associates Inc.
19,000 $37,620 $136,420 $98,800 262.63%
TGI
Torrey Growth & Income Advisors Torrey Growth & Income Advisors
55,450 $405,062 $398,131 -$6,931 -1.71%